Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	647	453	311.66	243.78	234.31	228.63
Short-Term Investments	25.58	14.19	41.8	79.33	-	-
Cash & Short-Term Investments	672.58	467.19	353.46	323.12	234.31	228.63
Cash Growth	63.85%	32.17%	9.39%	37.90%	2.48%	834.83%
Receivables	100.65	83.03	74.14	54.74	34.84	22.18
Inventory	6.88	7.2	5.36	4.3	4.43	3.82
Prepaid Expenses	23.31	13.71	12.57	9.35	7.64	6.96
Other Current Assets	35.38	8.12	5.54	8.79	3.22	1.3
Total Current Assets	838.8	579.25	451.07	400.29	284.44	262.89
Property, Plant & Equipment	2.67	3.38	2.72	2.89	4.12	0.94
Long-Term Investments	105.83	108.87	72.17	22.57	-	-
Other Intangible Assets	95.38	113.26	137.11	160.95	143.92	162.34
Long-Term Deferred Tax Assets	157.08	190.4	144.16	85.94	-	-
Other Long-Term Assets	8.46	4.03	4.22	1.24	0.97	0.9
Total Assets	1,208	999.2	811.45	673.87	433.44	427.07
Accounts Payable	26.34	13.74	17.73	3.79	1	2.56
Accrued Expenses	161.24	139.42	123.24	71.47	49.41	31.67
Current Portion of Long-Term Debt	20	16.25	15	2	2	-
Current Portion of Leases	0.83	1.32	1.44	1.61	1.36	-
Other Current Liabilities	15	4.35	6.37	0.01	-	100.31
Total Current Liabilities	223.4	175.08	163.78	78.88	53.78	134.54
Long-Term Debt	148.51	163.02	178.57	189.65	189.98	194.25
Long-Term Leases	0.4	0.82	1.08	0.98	2.4	-
Other Long-Term Liabilities	0.78	1.13	1.03	1.53	0.78	1.11
Total Liabilities	373.1	340.05	344.46	271.03	246.94	329.89
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	696.35	656.87	610.27	675.12	640.1	585.37
Retained Earnings	138.42	2.22	-143.28	-272.13	-453.6	-488.2
Comprehensive Income & Other	0.36	0.07	0	-0.15	-	-
Total Common Equity	835.12	659.16	466.99	402.84	186.51	97.18
Shareholders' Equity	835.12	659.16	466.99	402.84	186.51	97.18
Total Liabilities & Equity	1,208	999.2	811.45	673.87	433.44	427.07
Total Debt	169.73	181.41	196.09	194.24	195.74	194.25
Net Cash (Debt)	502.85	285.78	157.38	128.88	38.57	34.38
Net Cash Growth	123.26%	81.59%	22.11%	234.19%	12.17%	-
Net Cash Per Share	8.58	4.94	2.61	2.11	0.65	1.33
Filing Date Shares Outstanding	57.6	57.35	56.77	59.62	58.87	56.89
Total Common Shares Outstanding	57.6	57.14	56.77	59.62	58.83	56.89
Working Capital	615.4	404.17	287.29	321.4	230.66	128.35
Book Value Per Share	14.50	11.53	8.23	6.76	3.17	1.71
Tangible Book Value	739.74	545.89	329.88	241.89	42.59	-65.16
Tangible Book Value Per Share	12.84	9.55	5.81	4.06	0.72	-1.15

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q